Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Beyond Herceptin: Kadcyla Carries Torch Across Lines Of HER2 Therapy

Mar 04 2013

• By Emily Hayes

Related Content

Roche’s Oncology Output Could Lead To Reimbursement Problems Down The Line

Jan 30 2013

Expanded Colorectal Cancer Claim Moves <em>Avastin</em> Toward Continuous Use

Jan 25 2013

Roche Third-Quarter Pipeline Adjustments Include Advancements, Delays

Oct 17 2012

ASCO Data Support Roche’s Grand Plan For Non-Stop Avastin Treatment

Jun 11 2012

Beyond Herceptin, Roche Readies Breast Cancer Successors, Braces For Biosimilars

Jun 11 2012

Buoyed By T-DM1 EMILIA Data, Roche Leaps To Early Breast Cancer Trial

Jun 04 2012

Perjeta Approval Heralds Roche’s Next Wave Of Breast Cancer Drugs

Jun 10 2012

Related Companies

Roche Holding AG

Genentech, Inc.

Novartis AG

Additional Topics

Regulation Approvals Clinical Trials

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window